Larry Taft Nelsen, MD in Austin, MN - Pathology

Larry Taft Nelsen, MD is a Pathology - Clinical Pathology/laboratory Medicine physician based in Austin, Minnesota. Larry Taft Nelsen is licensed to practice in Minnesota (license number 20617) and his current practice location is 1000 1st Dr Nw, Austin, Minnesota. He can be reached at his office (for appointments etc.) via phone at (507) 434-1092.

NPI number for Larry Taft Nelsen is 1821074154 and his current mailing address is 1000 1st Dr Nw, Austin, Minnesota. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1821074154.

Contact Information

	Larry Taft Nelsen, MD
	1000 1st Dr Nw, Austin, MN 55912-2941
	(507) 434-1092
	(507) 434-1477

Physician's Profile

Full Name	Larry Taft Nelsen
Gender	Male
Speciality	Pathology - Clinical Pathology/laboratory Medicine
Location	1000 1st Dr Nw, Austin, Minnesota
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1821074154
Provider Enumeration Date: 12/19/2005
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Larry Taft Nelsen such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1821074154	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207ZP0105X	Pathology - Clinical Pathology/laboratory Medicine	20617 (Minnesota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Larry Taft Nelsen is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Larry Taft Nelsen, MD 1000 1st Dr Nw, Austin, MN 55912-2941 Ph: (507) 434-1092	Larry Taft Nelsen, MD 1000 1st Dr Nw, Austin, MN 55912-2941 Ph: (507) 434-1092

News Archive

Rigel earns $25M milestone payment from Astrazeneca for clinical development of fostamatinib

Rigel Pharmaceuticals, Inc. today announced that it has earned $25 million from AstraZeneca for the fulfillment of two major milestones in the agreement the two companies have regarding the clinical development of fostamatinib (R788), a novel oral syk inhibitor. The first milestone is for initiation of the phase 3 clinical program with fostamatinib in patients with rheumatoid arthritis (RA) that was announced by AstraZeneca earlier today.

Researchers discover that ATP transmits temperature information to afferent sensory neurons

A Japanese research group led by Prof. Makoto Tominaga and Dr. Sravan Mandadi (National Institute for Physiological Sciences: NIPS) found that ATP plays a key role in transmitting temperature information from skin keratinocytes to afferent sensory neurons. Their findings were presented in the Pflugers Archiv European Journal of Physiology published on October 2009.

WPI professor receives AHA fellowship for research into cardiovascular disease

Dalin Tang, professor of mathematical sciences and biomedical engineering at Worcester Polytechnic Institute (WPI), has been elected a fellow of the American Heart Association (AHA). Tang was elected to fellowship by the AHA's Council on Basic Cardiovascular Sciences in recognition of his "major and productive contributions in cardiovascular basic science."

Vascular stabilization biomarker helps optimize timing of anticancer therapies

Angiogenesis, the formation of new blood vessels, is essential for tumor growth. A new study reported in The American Journal of Pathology describes a vascular stabilization biomarker that can visualize blood vessel activity, thus optimizing the timing of anticancer therapies including anti-angiogenics.

Smokers at greater risk of schizophrenia and psychotic disorders

A team of researchers from University of Queensland have found that tobacco use is associated with an increased risk of psychotic disorders including schizophrenia.

Larry Taft Nelsen, MD - Pathology in Austin, MN